Developing integrated solutions for molecular differential diagnosis; developing a technology platform that allows multiplex molecular differential diagnoses carried out in a fashion that is high throughput, semi-quantitative, automatic, and with a closed system; studying the immunorepertoire of different autoimmune diseases and cancers using multiplex PCR and high-throughput gene sequencing.